Dynamic Atlas-Based Segmentation and Quantification of Neuromelanin-Rich Brainstem Structures in Parkinson Disease
暂无分享,去创建一个
Mikel Ariz | María A. Pastor | Carlos Ortiz-de-Solórzano | Arrate Muñoz-Barrutia | Ricardo C. Abad | Gabriel Castellanos | Martín Martínez | María A. Fernández-Seara | Pau Pastor | P. Pástor | Gabriel Castellanos | M. Fernández-Seara | M. Pastor | M. Ariz | A. Muñoz-Barrutia | Martín Martínez | C. Ortíz-de-Solórzano | M. Martínez | Ricardo C. Abad
[1] Daniel Rueckert,et al. Nonrigid registration using free-form deformations: application to breast MR images , 1999, IEEE Transactions on Medical Imaging.
[2] Takashi Nihashi,et al. Visualization of neuromelanin in the Substantia nigra and locus ceruleus at 1.5T using a 3D-gradient echo sequence with magnetization transfer contrast. , 2008, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[3] K. Kashihara,et al. Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson’s disease , 2011, Journal of Clinical Neuroscience.
[4] Dorothee P Auer,et al. In Vivo Assessment of Brainstem Depigmentation in Parkinson Disease: Potential as a Severity Marker for Multicenter Studies. , 2017, Radiology.
[5] R Weissleder,et al. Paramagnetic metal scavenging by melanin: MR imaging. , 1997, Radiology.
[6] Abbas F. Sadikot,et al. Patch-based label fusion segmentation of brainstem structures with dual-contrast MRI for Parkinson’s disease , 2015, International Journal of Computer Assisted Radiology and Surgery.
[7] Nicolas Guizard,et al. Investigation of morphometric variability of subthalamic nucleus, red nucleus, and substantia nigra in advanced Parkinson's disease patients using automatic segmentation and PCA‐based analysis , 2014, Human brain mapping.
[8] Dorothee P Auer,et al. T1‐Weighted MRI shows stage‐dependent substantia nigra signal loss in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[9] Daniel Rueckert,et al. Comparison and Evaluation of Segmentation Techniques for Subcortical Structures in Brain MRI , 2008, MICCAI.
[10] Eri Shibata,et al. Neuromelanin-Sensitive MRI : Basics, Technique, and Clinical Applications (Review Article) , 2008 .
[11] Sergio Cerutti,et al. Contrast mechanisms associated with neuromelanin‐MRI , 2017, Magnetic resonance in medicine.
[12] Josien P W Pluim,et al. Multiatlas-based segmentation with preregistration atlas selection. , 2013, Medical physics.
[13] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[14] Mert R. Sabuncu,et al. Multi-atlas segmentation of biomedical images: A survey , 2014, Medical Image Anal..
[15] Cyril Poupon,et al. 7 tesla magnetic resonance imaging: A closer look at substantia nigra anatomy in Parkinson's disease , 2014, Movement disorders : official journal of the Movement Disorder Society.
[16] Shinya Fujii,et al. Correlation between pathology and neuromelanin MR imaging in Parkinson’s disease and dementia with Lewy bodies , 2013, Neuroradiology.
[17] Delbert Dueck,et al. Clustering by Passing Messages Between Data Points , 2007, Science.
[18] C. Morgado,et al. Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients , 2015, European journal of neurology.
[19] Eri Shibata,et al. Age-related changes in locus ceruleus on neuromelanin magnetic resonance imaging at 3 Tesla. , 2006, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[20] S. Gilman,et al. Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.
[21] Carlos Ortiz-de-Solorzano,et al. Atlas-based segmentation of brainstem regions in neuromelanin-sensitive magnetic resonance images , 2015, Medical Imaging.
[22] Notger G. Müller,et al. Optimal Cut-Off Value for Locus Coeruleus-to-Pons Intensity Ratio as Clinical Biomarker for Alzheimer’s Disease: A Pilot Study , 2017, Journal of Alzheimer's disease reports.
[23] Jesper Jeppesen,et al. Evaluation of the noradrenergic system in Parkinson’s disease: an 11C-MeNER PET and neuromelanin MRI study , 2018, Brain : a journal of neurology.
[24] Yasuo Terayama,et al. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease , 2006, Neuroreport.
[25] Max A. Viergever,et al. elastix: A Toolbox for Intensity-Based Medical Image Registration , 2010, IEEE Transactions on Medical Imaging.
[26] Hiroki Shirato,et al. 3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of Parkinson’s disease , 2013, Neuroradiology.
[27] Carlos Ortiz-de-Solorzano,et al. Combination Strategies in Multi-Atlas Image Segmentation: Application to Brain MR Data , 2009, IEEE Transactions on Medical Imaging.
[28] C. Adler,et al. Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. , 2013, Brain : a journal of neurology.
[29] Meritxell Bach Cuadra,et al. A review of atlas-based segmentation for magnetic resonance brain images , 2011, Comput. Methods Programs Biomed..
[30] Benoit M. Dawant,et al. Morphometric analysis of white matter lesions in MR images: method and validation , 1994, IEEE Trans. Medical Imaging.
[31] Masayuki Satoh,et al. A longitudinal study of neuromelanin-sensitive magnetic resonance imaging in Parkinson’s disease , 2016, Neuroscience Letters.
[32] Silvia Marino,et al. Differences between conventional and non-conventional MRI techniques in Parkinson’s disease , 2013 .
[33] Yasuo Terayama,et al. Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging , 2013, Neuroscience Letters.
[34] Dimo Ivanov,et al. High-resolution in vivo imaging of human locus coeruleus by magnetization transfer MRI at 3T and 7T , 2017, NeuroImage.
[35] Angelo Antonini,et al. Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease. , 2017, Journal of Parkinson's disease.
[36] Mark A. Eckert,et al. Histologic validation of locus coeruleus MRI contrast in post-mortem tissue , 2015, NeuroImage.
[37] Carlos Ortiz-de-Solorzano,et al. Automated Neuromelanin Imaging as a Diagnostic Biomarker for Parkinson's Disease , 2015, Movement disorders : official journal of the Movement Disorder Society.